<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Continuity of Care Document</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Note</a></li><li><a href="#id2">Problems</a></li><li><a href="#id3">Allergies and Adverse Reactions</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Procedures</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Results</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Encounters</a></li><li><a href="#id10">Plan of Treatment</a></li><li><a href="#id11">Health Concerns</a></li><li><a href="#id12">Goals</a></li><li><a href="#id13">Assessments</a></li><li><a href="#id14">Medical Equipment</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Note</a></h3><div><table><colgroup><col width="95%"/></colgroup><tbody class="xRowGroup" ID="_db8401eb-4eac-43be-aba6-102e0b633c47"><tr><td><span class="content_span">Ead [REDACTED] N MD</span><span class="xLabel"> - </span><span class="content_span">[REDACTED]</span></td></tr><tr><td><span class="xIndent"> •</span><content class="xSecondary xContentWrapping"><span class="content_span">                        [REDACTED][REDACTED]
                           [REDACTED][REDACTED]
                         OPERATIVE OR PROCEDURE REPORT

PATIENT'S NAME: [REDACTED]               UNIT NO: W000904941
DOB: [REDACTED]                              ACCOUNT NO: W00021826455
ATT. PHYSICIAN:[REDACTED] N  MD               PT TYPE: DEP SDC
ADMISSION DATE:                               ROOM NO:


SURGEON:  [REDACTED], M.D.

DATE OF PROCEDURE:  [REDACTED]

PREOPERATIVE DIAGNOSIS:  Large left hydrocele.

POSTOPERATIVE DIAGNOSIS:  Large left hydrocele.

PROCEDURE:  Left hydrocelectomy.

ANESTHESIA:  LMA.

COMPLICATIONS:  None.

JUSTIFICATION FOR PROCEDURE:  This is an [REDACTED] male with history of large
symptomatic left hydrocele causing significant discomfort.  In addition to
hydrocelectomy, I have discussed with the patient at length the procedure,
potential complications.  Discussed risks of infection, bleeding, anesthetic
risks, postop pain, hematoma, recurrence of the hydrocele.  The patient signed
informed consent.

PROCEDURE IN DETAIL:  The patient was brought to the operating room, underwent
LMA anesthesia, placed in supine position, prepped and draped in the usual
sterile fashion.  Received preoperative antibiotics and sequential compression
boots placed to lower extremities.  Prior to induction of anesthesia, time-out
was performed.  A left hemiscrotal incision was made in a horizontal fashion.
The different layers of the scrotum were opened.  The hydrocele was then
delivered through the scrotal wound.  It was quite tense and large.  Upon
delivering the hydrocele, it was dissected out completely.  The hydrocele was
then opened.  Dark old blood was drained.  No way testicle was identifiable.
It appeared that the testicle had become necrotic and atrophied.  At one point,
it was unclear if this could be a scrotal hernia, but general surgeon was
called to evaluate.  The intraoperative consult was done.  They inspected, did
an exam intraoperatively and confirmed that it was not a scrotal hernia.  No
communication with the peritoneal cavity.  The hydrocele sac was then opened up
completely and excised.  There was no identifiable testicle in this area.  Once
completed, most of the sac was removed.  The area was irrigated copiously and
hemostasis was achieved.  The dead space was closed with 3-0 chromic suture
material in interrupted fashion.  Skin was closed with 4-0 chromic suture
material in interrupted fashion.  A 0.25% Marcaine plain, 10 cc injected.  The
patient was extubated.  Scrotal support and fluffs were placed.  The patient
extubated and sent to the recovery room in stable fashion.  Follow up in my
office [REDACTED].

[REDACTED], M.D.

PATIENT NAME: [REDACTED]                ACCOUNT #: W00021826455




DE/Aquity
DD:  [REDACTED] 15:38
DT:  [REDACTED] 21:58
Job #:  180847 / 1056800223

cc:    [REDACTED], [REDACTED] by [REDACTED] MD On [REDACTED] 02:14:23 PM





Electronically Signed by [REDACTED], MD on [REDACTED] at 0214









































PATIENT NAME: [REDACTED]                ACCOUNT #: W00021826455</span></content></td></tr></tbody></table></div><h3><a name="id2" href="#toc">Problems</a></h3><div><p>
    No Information
</p></div><h3><a name="id3" href="#toc">Allergies and Adverse Reactions</a></h3><div><table><colgroup><col width="40%"/><col width="20%"/><col width="40%"/></colgroup><tbody><tr ID="_47c3069d-1c22-4914-b26f-cf3b3633ea1c"><td><span class="content_span">No Known Allergies</span><span class="content_span"> (</span><span class="xSecondary">Allergy</span><span class="content_span">)</span><br/></td><td><span class="xSecondary">Onset: [REDACTED]</span></td><td/></tr></tbody></table></div><h3><a name="id4" href="#toc">Medications</a></h3><div><table><colgroup><col width="40%"/><col width="20%"/><col width="40%"/></colgroup><tbody class="xRowGroup"><tr ID="_d03e76dd-9f86-4773-8e25-13098bbf07de"><td><content class="xContentWrapping"><span class="content_span">1 ML ketorolac tromethamine 15 MG/ML Injection</span><span class="xLabel">; </span><span class="xSecondary">15 MILLIGRAM  ONCE</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] X MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
MAX DOSE/DAY=120MG FOR PATIENTS &lt; [REDACTED]
MAX DOSE/DAY=60MG FOR PATIENTS &gt; [REDACTED]</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_02a4f1e1-098b-48c3-8155-b943d5270ff0"><td><content class="xContentWrapping"><span class="content_span">oxyCODONE hydrochloride 5 MG Oral Tablet</span><span class="xLabel">; </span><span class="xSecondary">5 MILLIGRAM  ONCE</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] X MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**THIS DRUG IS A NARCOTIC ANALGESIC**
**Side effects may include nausea/vomiting, constipation**</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_f1cff860-fb84-484b-a199-cc568bedafe7"><td><content class="xContentWrapping"><span class="content_span">BUPivacaine hydrochloride 2.5 MG/ML Injectable Solution [Sensorcaine]</span><span class="xLabel">; </span><span class="xSecondary">Provider Administration Instructions:
**THIS DRUG IS A TOPICAL ANESTHETIC**
**BUPIVACAINE 0.25% = 75 MG/30 ML**</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">Provider Administration Instructions:
**THIS DRUG IS A TOPICAL ANESTHETIC**
**BUPIVACAINE 0.25% = 75 MG/30 ML**</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_516bbc11-d22c-4915-8ad4-b16d016b9731"><td><content class="xContentWrapping"><span class="content_span">bacitracin zinc 0.5 UNT/MG Topical Ointment</span><span class="xLabel">; </span><span class="xSecondary">Provider Administration Instructions:
THIS IS A TOPICAL ANTIBIOTIC
Common side effects may include pruritus, burning,
inflammation or hypersensitivity to components.
UNIT DOSE PRODUCT: 0.9 GM  PACKET</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">Provider Administration Instructions:
THIS IS A TOPICAL ANTIBIOTIC
Common side effects may include pruritus, burning,
inflammation or hypersensitivity to components.
UNIT DOSE PRODUCT: 0.9 GM  PACKET</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_22213d0e-0192-47bb-938e-299edc9ede31"><td><content class="xContentWrapping"><span class="content_span">0.5 ML HYDROmorphone hydrochloride 1 MG/ML Prefilled Syringe</span><span class="xLabel">; </span><span class="xSecondary">0.1 MILLIGRAM  Q5M PRN</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] M MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**For Use in PACU Dept ONLY**
*Caution: Each Dilaudid 2mg is equivalent to Morphine 13mg*</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_b864c050-b23d-4bf5-b558-cb7d31a6ed46"><td><content class="xContentWrapping"><span class="content_span">1 ML ePHEDrine sulfate 50 MG/ML Injection</span><span class="xLabel">; </span><span class="xSecondary">5 MILLIGRAM  Q5M PRN</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] M MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**For Use in PACU Dept ONLY**</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_231922bf-bb10-46a4-8222-a3b66521047b"><td><content class="xContentWrapping"><span class="content_span">0.5 ML HYDROmorphone hydrochloride 1 MG/ML Prefilled Syringe</span><span class="xLabel">; </span><span class="xSecondary">0.25 MILLIGRAM  Q5M PRN</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] M MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**For Use in PACU Dept ONLY**
*Caution: Each Dilaudid 2mg is equivalent to Morphine 13mg*</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_da4eab93-124f-41ff-b0c8-16d2afa18133"><td><content class="xContentWrapping"><span class="content_span">0.5 ML HYDROmorphone hydrochloride 1 MG/ML Prefilled Syringe</span><span class="xLabel">; </span><span class="xSecondary">0.5 MILLIGRAM  Q5M PRN</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**For Use in PACU Dept ONLY**
*Caution: Each Dilaudid 2mg is equivalent to Morphine 13mg*</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_ca1b756b-d40d-407f-a4a6-859e8ffa16cb"><td><content class="xContentWrapping"><span class="content_span">labetalol hydrochloride 5 MG/ML Injectable Solution</span><span class="xLabel">; </span><span class="xSecondary">5 MILLIGRAM  Q5M PRN</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**For Use in PACU Dept ONLY**
**Multi-Dose vial**
**Inject IV Push doses over 2 minutes**</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_b1a6bfae-3b9c-4565-9e72-c6740a0034df"><td><content class="xContentWrapping"><span class="content_span">1 ML naloxone hydrochloride 0.4 MG/ML Injection</span><span class="xLabel">; </span><span class="xSecondary">0.04 MILLIGRAM  Q3M PRN</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**For Use in PACU Dept ONLY**
**NOTE DOSE: 0.04 MG = 0.1 ML ONLY**</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_cbcb6891-173c-40e4-bb57-c2bbf9211df6"><td><content class="xContentWrapping"><span class="content_span">1 ML hydrALAZINE hydrochloride 20 MG/ML Injection</span><span class="xLabel">; </span><span class="xSecondary">2 MILLIGRAM  Q10M PRN</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] M MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**For Use in PACU Dept ONLY**</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_665f84c3-c846-485d-9569-9979ba91f7a8"><td><content class="xContentWrapping"><span class="content_span">ondansetron 2 MG/ML Injectable Solution [Zofran]</span><span class="xLabel">; </span><span class="xSecondary">4 MILLIGRAM  ASDIR</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**For Use in PACU Dept ONLY**
Rx 17208751 DC'd while checking ints/dups/alls on this Rx.</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_27b4463a-e19e-475d-8808-b609d0193d6c"><td><content class="xContentWrapping"><span class="content_span">propofol 10 MG/ML Injectable Suspension</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_1512f289-818c-4076-a4c5-602996447f02"><td><content class="xContentWrapping"><span class="content_span">lidocaine hydrochloride 10 MG/ML Injectable Solution</span><span class="xLabel">; </span><span class="xSecondary">Provider Administration Instructions:
**HIGH RISK MEDICATION**</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">Provider Administration Instructions:
**HIGH RISK MEDICATION**</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_59236795-f7a5-45a6-a007-830d2df899e3"><td><content class="xContentWrapping"><span class="content_span">2 ML fentaNYL 0.05 MG/ML Injection</span><span class="xLabel">; </span><span class="xSecondary">Provider Administration Instructions:
THIS IS A NARCOTIC ANALGESIC
(C-II CONTROLLED SUBSTANCE)
Common side effects may include respiratory depression,
sedation, Headache, nervousness, sleep disturbances,
dysphoria, euphoria, lightheadedness, alterations of mood</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">Provider Administration Instructions:
THIS IS A NARCOTIC ANALGESIC
(C-II CONTROLLED SUBSTANCE)
Common side effects may include respiratory depression,
sedation, Headache, nervousness, sleep disturbances,
dysphoria, euphoria, lightheadedness, alterations of mood</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_96b8574f-a4ec-45ac-911b-04b2c584f3d5"><td><content class="xContentWrapping"><span class="content_span">propofol 10 MG/ML Injectable Suspension</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_6affa260-5741-4898-a2ab-df84b7da3b57"><td><content class="xContentWrapping"><span class="content_span">10 ML sodium chloride 9 MG/ML Prefilled Syringe</span><span class="xLabel">; </span><span class="xSecondary">11111110
Provider Administration Instructions:
THIS IS A CEPHALOSPORIN ANTIBIOTIC.
*Cefazolin 2 GM dose = 2 cefazolin 1 GM vials   2 NS vials*
*Dilute each 1 GM vial with 10 ml normal saline*
*Administer 2 GM dose IV push over 6 minutes @ 200 ml/hr*</span><br/></content></td><td><span class="content_span">Ead [REDACTED] N MD</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
THIS IS A CEPHALOSPORIN ANTIBIOTIC.
*Cefazolin 2 GM dose = 2 cefazolin 1 GM vials   2 NS vials*
*Dilute each 1 GM vial with 10 ml normal saline*
*Administer 2 GM dose IV push over 6 minutes @ 200 ml/hr*</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_cf9f3dc8-2e2c-4399-9f2d-5abf1bda8359"><td><content class="xContentWrapping"><span class="content_span">acetaminophen 500 MG Oral Tablet</span><span class="xLabel">; </span><span class="xSecondary">1000 MILLIGRAM  ONCALL</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">2 </span><br/></content></td><td><span class="content_span">[REDACTED] R4 DO</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**Premed For Use in PreOp-Dept ONLY**
DO NOT EXCEED 4 GRAMS PER DAY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_3dbc5078-eccd-49fb-b484-10eb465c19ff"><td><content class="xContentWrapping"><span class="content_span">ondansetron 2 MG/ML Injectable Solution [Zofran]</span><span class="xLabel">; </span><span class="xSecondary">4 MILLIGRAM  ONCALL</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] R4 DO</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**Premed For Use On Call to OR-Dept ONLY**
**Ondansetron Choice If patient is NPO**</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_4a47b83a-21dd-4801-bb50-74f90744c9e8"><td><content class="xContentWrapping"><span class="content_span">Dexamethasone 4 MG/ML Injectable Solution</span><span class="xLabel">; </span><span class="xSecondary">4 MILLIGRAM  ONCALL</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] R4 DO</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**Premed For Use On Call to OR-Dept ONLY**
**Dexamethasone Used to Reduce Post Op Nausea**
THIS IS A GLUCOCORTICOID
Common side effects may include impaired wound healing,
masked signs of infection, [REDACTED] syndrome with prolonged</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_78b0ba27-7e64-4569-ae6c-79debb1d1656"><td><content class="xContentWrapping"><span class="content_span">gabapentin 100 MG Oral Capsule [Neurontin]</span><span class="xLabel">; </span><span class="xSecondary">100 MILLIGRAM  ONCALL</span><br/><span class="xLabel"> Quantity: </span><span class="content_span">1 </span><br/></content></td><td><span class="content_span">[REDACTED] R4 DO</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Status: </span><span class="content_span">Discontinued</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
THIS IS AN ANTICONVULSANT
Common side effects may include drowsiness, fatigue,
weight gain, back pain, peripheral edema, dyspepsia,
dry mouth, and constipation.</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_8dc6b680-30e2-47d2-a11e-21fded1cbb11"><td><content class="xContentWrapping"><span class="content_span">calcium chloride 0.2 MG/ML / potassium chloride 0.3 MG/ML / sodium chloride 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution</span><span class="xLabel">; </span><span class="xSecondary">11111110
Provider Administration Instructions:
**Premed For Use On Call to OR-Dept ONLY**
**THIS IS USED AS AN ELECTROLYTE REPLACEMENT**</span><br/></content></td><td><span class="content_span">[REDACTED] R4 DO</span></td><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><span class="xLabel xSecondary"> End: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">11111110
Provider Administration Instructions:
**Premed For Use On Call to OR-Dept ONLY**
**THIS IS USED AS AN ELECTROLYTE REPLACEMENT**</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_2d71ccfc-7141-4846-b888-660df3661a75"><td><content class="xContentWrapping"><span class="content_span">tamsulosin hydrochloride 0.4 MG Oral Capsule [Flomax]</span><span class="xLabel">; </span><span class="xSecondary">0.4 MILLIGRAM ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">0.4 MG PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_56c8886c-d356-4333-8141-b2804346c9e8"><td><content class="xContentWrapping"><span class="content_span">atorvastatin 40 MG Oral Tablet</span><span class="xLabel">; </span><span class="xSecondary">40 MILLIGRAM ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">40 MG PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_4b60dd5a-8582-493a-881c-bac0898eb717"><td><content class="xContentWrapping"><span class="content_span">empagliflozin 25 MG Oral Tablet [Jardiance]</span><span class="xLabel">; </span><span class="xSecondary">25 MILLIGRAM ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">25 MG PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_05c3c36a-fc32-4b90-bb6d-77cf53379633"><td><content class="xContentWrapping"><span class="content_span">lisinopril 40 MG Oral Tablet</span><span class="xLabel">; </span><span class="xSecondary">40 MILLIGRAM ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">40 MG PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_494b8715-ff52-4cfd-ad8e-326e773d44f1"><td><content class="xContentWrapping"><span class="content_span">carvedilol 12.5 MG Oral Tablet [Coreg]</span><span class="xLabel">; </span><span class="xSecondary">12.5 MILLIGRAM ORAL BID</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">12.5 MG PO BID</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_441b8795-230c-484d-b0ee-68e4796067fd"><td><content class="xContentWrapping"><span class="content_span">VELTASSA</span><span class="xLabel">; </span><span class="xSecondary">16.8 GRAM ORAL DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">16.8 GM PO DAILY</span></td></tr></tbody><tbody class="xRowGroup"><tr ID="_7f273da9-1b0f-4fbc-a94c-b70bf6c75a3e"><td><content class="xContentWrapping"><span class="content_span">Vyzulta</span><span class="xLabel">; </span><span class="xSecondary">1 DROP EACH EYE DAILY</span><br/></content></td><td/><td><span class="xLabel xSecondary">Start: </span><span class="xSecondary">[REDACTED]</span><br/><span class="xLabel">Comments: </span><span class="xSecondary">1 DROP EACH EYE DAILY</span></td></tr></tbody></table></div><h3><a name="id5" href="#toc">Procedures</a></h3><div><table><colgroup><col width="40%"/><col width="20%"/><col width="40%"/></colgroup><tbody class="xRowGroup"><tr ID="_23a5ad05-68da-4d69-847d-c8292e8c195b"><td><span class="content_span">REMOVAL OF HYDROCELE</span></td><td><span class="xLabel xSecondary">Date: </span><span class="xSecondary">[REDACTED]</span><br/></td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Social History</a></h3><div><p>
    No Information
</p></div><h3><a name="id7" href="#toc">Results</a></h3><div><table><colgroup><col width="20%"/><col width="40%"/><col width="40%"/></colgroup><tbody class="xRowGroup"><tr><td><span class="xSecondary">Glucose by Monitoring Device</span></td><td><span class="xLabel">Ordered On: </span><span class="content_span">[REDACTED]</span></td><td/></tr><tr ID="_349a46b5-54e6-42d3-ab8f-91aed3adb850"><td><span class="xSecondary xContentWrapping">[REDACTED] 15:59</span></td><td><span class="xSecondary">Glucose by Monitoring Device</span><span class="xSecondary"> 198</span><span class="xSecondary"> mg/dL</span><span class="xSecondary"> (High)</span></td><td><content><span class="xLabel xSecondary">Range: </span><span class="xSecondary">70</span><span class="xSecondary"> mg/dL</span><span class="xSecondary"> - </span><span class="xSecondary">110</span><span class="xSecondary"> mg/dL</span><br/></content></td></tr></tbody><tbody class="xRowGroup"><tr><td><span class="xSecondary">Glucose by Monitoring Device</span></td><td><span class="xLabel">Ordered On: </span><span class="content_span">[REDACTED]</span></td><td/></tr><tr ID="_a432fded-d9f5-4f2e-adec-5d68e7900f7b"><td><span class="xSecondary xContentWrapping">[REDACTED] 13:27</span></td><td><span class="xSecondary">Glucose by Monitoring Device</span><span class="xSecondary"> 202</span><span class="xSecondary"> mg/dL</span><span class="xSecondary"> (High)</span></td><td><content><span class="xLabel xSecondary">Range: </span><span class="xSecondary">70</span><span class="xSecondary"> mg/dL</span><span class="xSecondary"> - </span><span class="xSecondary">110</span><span class="xSecondary"> mg/dL</span><br/></content></td></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table class="xBorderBottom"><colgroup><col width="40%"/><col width="20%"/><col width="40%"/></colgroup><tbody class="xRowGroup"><tr><td><span class="content_span">[REDACTED] 15:52</span></td><td/><td/></tr><tr ID="_b3677c29-6002-4bfd-bd7e-c7c0e2b97d26"><td/><td><content><span class="xSecondary">Oxygen delivery devices: </span><span class="xSecondary"/></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">Simple mask</span></td></tr></tbody><tbody class="xRowGroup"><tr><td><span class="content_span">[REDACTED] 13:15</span></td><td/><td/></tr><tr ID="_870498f8-581c-4e48-8419-18bb709c04c5"><td/><td><content><span class="xSecondary">Pulse </span><span class="xSecondary">80</span></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">80</span></td></tr><tr ID="_14aec685-d4cb-43cc-b2a8-6906b66b0c28"><td/><td><content><span class="xSecondary">Respiratory Rate </span><span class="xSecondary">12</span></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">12</span></td></tr><tr ID="_6002dbe2-0b8a-41aa-be09-e6e488b4dc20"><td/><td><content><span class="xSecondary">Temperature </span><span class="xSecondary">97.1</span><span class="xSecondary"> f </span></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">97.1</span></td></tr><tr ID="_970fe9f1-0f6a-4d67-88d0-129a7226ee77"><td/><td><content><span class="xSecondary">O2 SAT </span><span class="xSecondary">100</span><span class="xSecondary"> % </span></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">100</span></td></tr><tr ID="_aa6824b1-b3d3-4036-8476-76438e8025e1"><td/><td><content><span class="xSecondary">BP Systolic </span><span class="xSecondary">142</span><span class="xSecondary"> mm[Hg] </span></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">142</span></td></tr><tr ID="_f02cc2d5-393f-4610-a523-dd1bb37d9461"><td/><td><content><span class="xSecondary">BP Diastolic </span><span class="xSecondary">64</span><span class="xSecondary"> mm[Hg] </span></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">64</span></td></tr></tbody><tbody class="xRowGroup"><tr><td><span class="content_span">[REDACTED] 11:42</span></td><td/><td/></tr><tr ID="_8b3e5882-8331-4df3-94f6-2ad340d25137"><td/><td><content><span class="xSecondary">Height </span><span class="xSecondary">5.08333334</span><span class="xSecondary"> [ft_us] </span></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">5</span></td></tr><tr ID="_2e48c0a7-80d6-4b6c-af86-10257632f5d2"><td/><td><content><span class="xSecondary">Weight </span><span class="xSecondary">73.182</span><span class="xSecondary"> kg </span></content></td><td><span class="xLabel xSecondary">Comments: </span><span class="xSecondary">73.182</span></td></tr></tbody></table></div><h3><a name="id9" href="#toc">Encounters</a></h3><div><table><colgroup><col width="40%"/><col width="20%"/><col width="40%"/></colgroup><tbody class="xRowGroup"><tr ID="_8c8bea97-fe6f-4e86-b1b5-d8fff8820c32"><td><span class="content_span">short stay</span><br/><content><span class="xLabel xSecondary">Encounter Reason:</span><span class="xSecondary">N43.3</span></content><br/><content><span class="xSecondary xLabel">Encounter Diagnosis:</span><span class="xSecondary">Hyperlipidemia, unspecified</span><span class="xSecondary">, </span><span class="xSecondary">Type 2 diabetes mellitus with hyperglycemia</span><span class="xSecondary">, </span><span class="xSecondary">Obesity, unspecified</span><span class="xSecondary">, </span><span class="xSecondary">Type 2 diabetes mellitus with diabetic chronic kidney disease</span><span class="xSecondary">, </span><span class="xSecondary">Anemia in chronic kidney disease</span><span class="xSecondary">, </span><span class="xSecondary">Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</span><span class="xSecondary">, </span><span class="xSecondary">Stage 3a chronic kidney disease</span><span class="xSecondary">, </span><span class="xSecondary">Type 2 diabetes mellitus with other specified complication</span><span class="xSecondary">, </span><span class="xSecondary">Pulmonary hypertension, unspecified</span><span class="xSecondary">, </span><span class="xSecondary">Chronic diastolic (congestive) heart failure</span><span class="xSecondary">, </span><span class="xSecondary">IMMUNODEFICIENCY DUE TO CONDITIONS CLASSIFIED ELSEWHERE</span><span class="xSecondary">, </span><span class="xSecondary">Long term (current) use of insulin</span><span class="xSecondary">, </span><span class="xSecondary">Personal history of nicotine dependence</span><span class="xSecondary">, </span><span class="xSecondary">Long term (current) use of oral hypoglycemic drugs</span><span class="xSecondary">, </span><span class="xSecondary">Personal history of malignant neoplasm of prostate</span><span class="xSecondary">, </span><span class="xSecondary">Body mass index (BMI) 30.0-30.9, adult</span><span class="xSecondary">, </span><span class="xSecondary">Hydrocele, unspecified</span></content></td><td><span class="xSecondary">[REDACTED] 12:23 </span><span class="xLabel xSecondary"> To </span><span class="xSecondary">[REDACTED] 12:23</span><br/><span class="xSecondary">Westside Reg</span><br/></td><td><span class="xLabel">Discharge Disposition: </span><span class="xSecondary">Discharged to home or self care (routine discharge)</span><br/></td></tr><tr ID="_81c3ff33-617b-4d56-aae3-b2180a561ba8"><td colspan="3"><span class="xIndent"> •</span><content class="xSecondary xContentWrapping"><span class="content_span">Ead [REDACTED] MD</span><span class="xLabel"> - </span><span class="content_span">[REDACTED]</span><br/><span class="content_span">
HCA [REDACTED][REDACTED] (COCWS)
Op/Inv Procedure Note - Brief
REPORT#:0318-1021  REPORT STATUS: Signed
DATE:[REDACTED] TIME: 1540

PATIENT: [REDACTED]                  UNIT #: W000904941
ACCOUNT#: W00021826455                  ROOM/BED:
DOB: [REDACTED] AGE: [REDACTED]      SEX: M         ATTEND: Ead,[REDACTED]  MD
ADM DT: [REDACTED]                          AUTHOR: [REDACTED] N  MD
REP SRV DT: [REDACTED]                  REP SRV TM: 1540
* ALL edits or amendments must be made on the electronic/computer document *


Op/Inv Proc Note - Brief TEXT

Brief Op/Inv Procedure Note
Note details:
*PRE-PROCEDURE DIAGNOSIS:
left hydrocele

*POST-PROCEDURE DIAGNOSIS:
Same

*PROCEDURE(S) PERFORMED:
left hydrocelectomy

*PRIMARY SURGEON:
EAD

*ASSISTANT(S):
[]

ANESTHETIC:
LMA

*ESTIMATED BLOOD LOSS in ml's:
minimal

*SPECIMEN(S) REMOVED:
[]

*COMPLICATIONS:
None[]

DRAIN(S):
None[]

TUBE(S):
None[]

IMPLANT(S):
None[]

FLUIDS:
[]

URINE OUTPUT:
[]

*FINDINGS:
[]

DISPOSITION:
To PACU[]


Electronically Signed by Ead,[REDACTED]  MD on [REDACTED] at 1540
RPT #: 0318-1021
***END OF REPORT***</span></content></td></tr></tbody><tbody class="xRowGroup"><tr ID="_b62dc2cb-63bd-4119-a497-5844c2b76cd2"><td><span class="content_span">pre-admission</span><br/><content><span class="xLabel xSecondary">Encounter Reason:</span><span class="xSecondary">DR EAD PT- PRE-SURGERY--WI</span></content><br/></td><td><span class="xSecondary">[REDACTED] 11:39 </span><br/><span class="xSecondary">[REDACTED] MD (Attending)</span><br/><span class="xSecondary">Westside Reg</span><br/></td><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">Plan of Treatment</a></h3><div>Plan of treatment may be documented in an alternate section</div><h3><a name="id11" href="#toc">Health Concerns</a></h3><div>Health concerns may be documented in an alternate section</div><h3><a name="id12" href="#toc">Goals</a></h3><div>Goals may be documented in an alternate section</div><h3><a name="id13" href="#toc">Assessments</a></h3><div>No assessment information available</div><h3><a name="id14" href="#toc">Medical Equipment</a></h3><div>No implantable device information available</div><br/><br/>
</body></html>